跳至主要内容
临床试验/NCT01021488
NCT01021488Unknown4 期

Rosuvastatin for Prevention of Deep Vein Thrombosis in Patients Undergoing Total Knee Replacement Arthroplasty: STOP DVT - A Prospective Randomized Controlled Trial

Hallym University Medical Center1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2009年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
180
试验地点
1
主要终点
Development of deep vein thrombosis diagnosed and confirmed by CT angiography at lower extremities

研究概览

简要总结

Deep vein thrombosis (DVT)is devastating disease which influencing the mortality and morbidity of patients at-risk like those undergoing orthopedic surgery.

Recent publication suggested HMO-co-A reductase inhibitor (statin) may reduce the occurrence rate of venous thromboembolism in apparently healthy persons.

The pleiotropic property of statin like antioxidant, antithrombotic, anti-inflammatory may have effect on the positive results.

We are investigating whether rosuvastatin is associated with lower incidence of deep vein thrombosis (DVT) in patients undergoing total knee replacement arthroplasty(TKRA)who are at-high risk for developing DVT

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are going to receive total knee replacement arthroplasty from any cause.
  • < 19 years old

排除标准

  • patients with cancer
  • Patients receiving anticoagulant agents from any cause
  • current statin users
  • expecting survival from other co-morbidity < 1year
  • Bed ridden patient
  • AST, ALT > 3times of upper normal limit
  • CK> upper normal limit
  • pregnancy
  • patients who receives hormone replacement therapy

研究组 & 干预措施

Experimental: Rosuvastatin + enoxaparin arm

Experimental

Rosuvastatin 20mg/day for 7days before and 7days after index surgery (total knee replacement arthroplasty, TKRA) Enoxaparin 40mg SQ/day 12hr before TKRA and from 1day to 7day after TKRA should be administered at the same time with rosuvastatin.

干预措施: Rosuvastatin 20mg/d for 14days (Drug)

enoxaparin only

Active Comparator

enoxaparin 40mg sq/day only starting 12hr before TKRA and from on day 1 to 7 after index surgery

干预措施: enoxaparin only (Drug)

结局指标

主要结局

Development of deep vein thrombosis diagnosed and confirmed by CT angiography at lower extremities

时间窗: 7days after index surgery

次要结局

  • D-dimer, lipid panel (Total cholesterol, TG, HDL, LDL), hsCRP, CK, transaminase, ALP(7days, 1month, 2month after index surgery)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验